---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-013642"
form_type: "8-K"
ticker: "QTRX"
cik: "0001503274"
company_name: "Quanterix Corp"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:09:03.206928+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quanterix Q2 revenue $31M (+32% YoY), net loss narrows to $6.1M; raises FY revenue guidance to $110-116M

## Summary
- Revenue $31.0M, +32% YoY, including $1.5M one-time product/license benefit; 9% sequential growth.
- GAAP gross margin 61.7% vs 37.1%; non-GAAP gross margin 56.4% vs 29.1%.
- Net loss $6.1M vs $24.9M prior year; near break-even cash flow; cash $329.5M.
- Launched LucentAD blood test for Alzheimer's; positive Bio-Hermes study correlation with amyloid PET.
- FY 2023 revenue outlook raised to $110-116M; cash burn lowered to $30-35M.

## SEC filing metadata
- accession: 0001558370-23-013642
- form_type: 8-K
- ticker: QTRX
- cik: 0001503274
- company_name: Quanterix Corp
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503274/000155837023013642/0001558370-23-013642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503274/000155837023013642/tmb-20230807x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-013642
- JSON: https://secwatch.observer/filing/0001558370-23-013642.json
- Plain text: https://secwatch.observer/filing/0001558370-23-013642.txt

## Key facts
- Earnings Releases
  Quanterix Corp reported second quarter ended June 30, 2023 results: revenue $31.0 million. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $31.0 million
  - Guidance: raised
  - Result: reported results
  source text: today announced financial results for the three months ended June 30, 2023. Second Quarter Financial Highlights ● Total revenue was $31.0 million versus prior year second quarter total revenue of $23.5 million, an increase of 32%. Second quarter revenue also increased 9% sequentially driven by increased Accelerator Lab and consumables revenue. Second quarter revenue includes a one-time benefit of approximately $1.5 million related to product and license agreements. ● GAAP gross margin was 61.7% compared to prior year second quarter GAAP gross margin of 37.1%. Non-GAAP gross margin was 56.4% compared to prior year second quarter non-GAAP gross margin of 29.1%. ● Net loss was $6.1 million compared to prior year second quarter net loss of $24.9 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1503274/000155837023013642/0001558370-23-013642-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.